Dernières publications

Sur cette page le lecteur peut obtenir une liste des derniers documents. Veuillez cliquer sur l'icône d'un type pour accéder pour accéder aux documents concernés. Les publications sont disponibles en HTML, PDF , DOC ou XLS format. Veuillez cliquer sur l'icône correspondante pour accéder à la publication.
Étendre le menu Sous-collections.
58 documents en 2 pages
 
 
Ouvrir ce document et afficher son contenu

Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis.

An:

2017;

Pages:

48;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Aura 2017: Second Australian Report on Antimicrobial Use and Resistance in Human Health. Sydney: Australian Commission on Safety and Quality in Health Care (Acsqhc); 2017

An:

2017;

Pages:

238;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Consultation on Financing of Essential Medicines. Manila, Philippines, 4-6 October 2006

An:

2007;

Pages:

58;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Developing Better Terms of Reference to Improve the Performance of Pharmaceutical Sector Committees: Case Studies from South Africa. Siaps Technical Brief Series, September 2017. (With Annex A: Guidelines for the Development of the Terms of Reference of a Committee)

An:

2017;

Pages:

18;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

An Equal Opportunity - Achieving Access 2030. Financing the Strategic Workplan to Address Global Health Research & Development Needs

An:

2017;

Pages:

20;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Fighting antimicrobial resistance. The contribution of pharmacists. 2015

An:

2015;

Pages:

39;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

First Meeting on Access to Medicines under Universal Health Coverage in the Asia-Pacific Region. Meeting Report, 18–19 September 2014 Seoul, Republic of Korea

An:

2014;

Pages:

126;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Global Priority Research Agenda for Improving Access to High-quality Affordable Assistive Technology

An:

2017;

Pages:

24;


Régions:

 
Ouvrir ce document et afficher son contenu

Guidance Document For Spontaneous Adverse Drug Reaction Reporting. Version: 1.0, 2014

An:

2014;

Pages:

80;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

A Guide to Aid the Selection of Diagnostic Tests. (Bull World Health Organ 2017;95:639–645)

An:

2017;

Pages:

7;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Guidelines for Conducting Clinical Trials - Sierra Leone

An:

2013;

Pages:

14;


 
Ouvrir ce document et afficher son contenu

Guidelines for Conducting Clinical Trials of Medicines, Food Supplements, Vaccines and Medical Devices in Sierra Leone

An:

2014;

Pages:

32;


 
Ouvrir ce document et afficher son contenu

Guidelines for Medicinal Product Registration - Sierra Leone

An:

2013;

Pages:

28;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. Replacement of Annex 2 of Who Technical Report Series, No. 964. Who Expert Committee on Biological Standardization, Sixty-seventh Report; Who Technical Report Series No. 1004, 2017, Annex 5

An:

2017;

Pages:

192;


Régions:

 
Ouvrir ce document et afficher son contenu

Guidelines on Regulatory Preparedness for Provision of Marketing Authorization of Human Pandemic Influenza Vaccines in Non-vaccine-producing Countries. Who Expert Committee on Biological Standardization, Sixty-seventh Report; Who Technical Report Series No. 1004, 2017, Annex 7

An:

2017;

Pages:

29;


Régions:

 
Ouvrir ce document et afficher son contenu

Health Technologies and Pharmaceuticals (HTP) Programme Annual Report 2016. WHO Regional Office for Europe

An:

2017;

Pages:

24;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Inventory of Key USAID and Global AMR-related System Strengthening Resources/Interventions. August 2017

An:

2017;

Pages:

15;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Meeting of Stakeholders for the “development of a Single Dose Malaria Cure of Artemether-lumefantrine Through a Nano-based Drug Delivery System", Health R&D Demonstration Project, 27 February 2017, Geneva. Summary Meeting Report

An:

2017;

Pages:

6;


Régions:

 
Ouvrir ce document et afficher son contenu

Options for Sustainable Funding of a Voluntary Pooled Fund to Support Health Research and Development. (Background document to EB140/21: “Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination”)

An:

2016;

Pages:

18;


Régions:

 
Ouvrir ce document et afficher son contenu

Pharmacovigilance Monitoring System (PViMS) User Guide: Active Reporting of Adverse Events - Philippines

An:

2017;

Pages:

29;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug Resistant Bacterial Infections, Including Tuberculosis

An:

2017;

Pages:

88;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Safety of Medicines in Sierra Leone - A Guide for Detecting and Reporting Adverse Drug Reactions - Why Health Professionals Need to Act?

An:

2005;

Pages:

19;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Second Meeting on Access to Medicines under Universal Health Coverage in the Asia Pacific Region. Meeting Report, 17–18 September 2015, Seoul, Republic of Korea

An:

2015;

Pages:

73;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Technology and Market Landscape for Hepatitis C Medicines. August 2017

An:

2017;

Pages:

140;


Documents similaires:

Régions:

 
 
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 7 novembre 2017